How should orthostatic hypotension be evaluated and managed in an 80‑year‑old woman presenting with dizziness and a drop in blood pressure upon sitting and standing?

Evaluation and Management of Orthostatic Hypotension in an 80-Year-Old Woman

This patient requires immediate orthostatic vital sign measurement to confirm orthostatic hypotension (OH), followed by medication review and stepwise non-pharmacological interventions before considering pharmacological therapy.

Diagnostic Confirmation

Perform bedside orthostatic vital signs using the simplified Schellong test: measure blood pressure and heart rate after 5 minutes supine, then at 1 and 3 minutes after standing 1. OH is confirmed by a drop in systolic BP ≥20 mmHg or diastolic BP ≥10 mmHg within 3 minutes of standing 2, 1.

• In elderly patients who cannot stand safely or if initial testing is negative despite high clinical suspicion, proceed to head-up tilt table testing at 60 degrees 1, 3
• Document whether symptoms (dizziness) occur during the BP drop to distinguish symptomatic from asymptomatic OH 4
• Measure heart rate response: a blunted heart rate increase (<15 bpm) suggests neurogenic OH, which may indicate early Parkinson's disease or related synucleinopathies 4, 5

Critical History and Physical Examination Elements

Medication review is paramount - identify and discontinue or reduce doses of causative agents including antihypertensives, diuretics, alpha-blockers, tricyclic antidepressants, and anticholinergic medications 1, 3, 6. High anticholinergic burden (ACB ≥2) significantly increases OH risk in frail elderly (OR 4.14) 6.

Assess for neurogenic versus non-neurogenic causes 4, 5:

• Neurogenic indicators: Parkinson's disease symptoms, autonomic neuropathy from diabetes, supine hypertension (systolic BP >140 mmHg when lying down)
• Non-neurogenic causes: dehydration, blood loss, anemia, cardiac dysfunction, prolonged bed rest

Screen for "coat hanger" pain (neck and shoulder pain from muscle hypoperfusion), visual disturbances, cognitive slowing, and unexplained falls - these are often missed atypical presentations in elderly patients 1, 3.

Stepwise Management Algorithm

Step 1: Address Reversible Causes (First Priority)

• Discontinue or reduce offending medications 4, 5, 3
• Correct volume depletion, anemia, or electrolyte abnormalities 3
• Treat underlying conditions (diabetes control, cardiac optimization) 1

Step 2: Non-Pharmacological Interventions (Foundation of Treatment)

Implement these measures for ALL patients 4, 5:

• Fluid and salt intake: Increase water to 2-2.5 liters daily and salt to 6-10 grams daily (unless contraindicated by heart failure) 5, 3
• Physical counterpressure maneuvers: Leg crossing, squatting, or tensing leg/abdominal muscles before and during standing 4, 1
• Compression garments: Waist-high compression stockings (30-40 mmHg) or abdominal binders 1, 3
• Positional modifications: Elevate head of bed 10-20 degrees to reduce supine hypertension and nocturnal diuresis 5, 3
• Avoid triggers: Hot environments, large meals, prolonged standing, rapid postural changes 4, 1
• Meal timing: Eat smaller, frequent meals to minimize postprandial hypotension 3

Step 3: Pharmacological Treatment (If Non-Pharmacological Measures Insufficient)

First-line agents 5, 1:

• Midodrine: Start 2.5-5 mg three times daily, titrate up to 10 mg three times daily. This is a peripheral alpha-1 agonist that increases vascular tone 5, 1, 3. Take last dose at least 4 hours before bedtime to avoid supine hypertension 3.

• Fludrocortisone: Start 0.1 mg daily, increase to 0.2-0.4 mg if needed. This mineralocorticoid expands plasma volume 5, 1. However, it has concerning long-term effects including hypokalemia, edema, and heart failure exacerbation 1.

Combination therapy: For severe cases unresponsive to monotherapy, combine midodrine with fludrocortisone 5.

Alternative agent: Droxidopa (norepinephrine precursor) is another first-line option, particularly for neurogenic OH 1.

Special Considerations for This 80-Year-Old Patient

• High prevalence: OH affects 20% of community-dwelling older adults, increasing to 30-50% in those with risk factors 7
• Mortality risk: OH is associated with up to 50% increased relative risk of all-cause mortality and significantly increased cardiovascular events and falls 1
• Asymptomatic presentation: Most elderly patients with OH have no symptoms or atypical symptoms, making screening vital in high-risk populations 7
• Supine hypertension: Check supine BP as this commonly coexists with neurogenic OH in elderly patients and complicates management 4, 5

Common Pitfalls to Avoid

• Do not assume dizziness equals OH without objective BP measurements - many elderly have orthostatic intolerance without meeting OH criteria 2
• Do not start pharmacological treatment before exhausting non-pharmacological measures and medication adjustments 4, 5
• Do not use fludrocortisone as monotherapy long-term due to adverse effects; prefer midodrine 1
• Do not overlook delayed OH (BP drop >3 minutes after standing), which requires prolonged standing measurements 2
• Do not treat supine hypertension aggressively if it worsens orthostatic symptoms 4, 5